(lp0
S"Biocept Inc  Scores Blue Cross Texas, Up 100% Insider Financial - Jan 11, 2017 Biocept Inc  gained more than 77% during Tuesday's session this week, and is up more than 100% on last week's close, on news that the company has picked up a fresh round of insurance coverage for its lead biopsy product.Stock Update : Here's Why Biocept Inc Shares Jumped 60% - Smarter AnalystBiocept, Inc.  Closed last trading session at $1.81 - TopChronicle"
p1
aS'Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy ... PR Newswire  - Mar 14, 2017 SAN DIEGO, March 14, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces a&nbsp;...Biocept  Enters Collaboration to Provide Liquid Biopsy Testing for Small ... - StreetInsider.com'
p2
aS'Biocept to Release 2016 Fourth Quarter and Full Year Financial Results and ... PR Newswire  - Feb 21, 2017 SAN DIEGO, Feb. 21, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that ...'
p3
aS'Valeant Pharmaceuticals Intl Inc  Running Low On Gas, Biocept Inc (BIOC ... Smarter Analyst - Mar 8, 2017 In the biotech-verse, Valeant Pharmaceuticals Intl Inc  and Biocept Inc  are in opposite standing. According to one of the best analysts on the Street, who has lately been zooming in with a vengeance on the troubled biotech giant ...Wall Street Movers News  Valeant Pharmaceuticals Intl Inc , Biocept ... - Wall Street Times '
p4
aS'Trading Scout: Watching Shares of Biocept Inc  Midway Monitor - 9 hours ago Investors may be looking to compare the current stock price of Biocept Inc  to some of its moving averages. After a recent check, the 200-day MA is resting at 1.56, and the 50-day is 1.95.'
p5
aS'Biocept Inc  Stockholders Get Letter From The CEO Journal Transcript - Feb 27, 2017 A letter sent by the Michael Nall, the chief executive officer of Biocept Inc , to shareholders has sought to underscore the strong position the pharmaceutical company is currently in, in the area of liquid biopsy.'
p6
aS'Stock Check: Viewing Levels for Biocept Inc  Rives Journal - Mar 21, 2017 Biocept Inc  presently has a 14-day Commodity Channel Index  of -38.02. The CCI was created to typically stay within the reading of -100 to +100.'
p7
aS"Buy, Sell or Hold? Analysts Approach: Biocept, Inc. , Avon Products, Inc ... The USA Commerce - Mar 9, 2017 Shares of Biocept, Inc.  surged 0.44% to $2.27. During the trading on 03/08/2017, Company's stock ranged from $2.23 to $2.75."
p8
aS'Biocept Announces Revised Presentation Time at the 27th Annual Oppenheimer ... Yahoo Finance - Mar 20, 2017 SAN DIEGO, March 20, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces a revised ...Global Liquid Biopsy Market is Growing at CAGR of 21.6% and Expected to Reach ... - EIN News '
p9
aS"Analyst's Proposition on Biocept, Inc. , W&amp;T Offshore, Inc.  The USA Commerce - Mar 15, 2017 Shares of Biocept, Inc.  surged 3.43% to $2.11. During the trading on 03/14/2017, Company's stock ranged from $2.04 to $2.22.Its time to give a fresh look to Biocept, Inc.  and W&amp;T Offshore, Inc.  - USA Commerce Daily"
p10
a.